PR Newswire August 1, 2022
FinancialBuzz.com News Commentary
NEW YORK, Aug. 1, 2022 /PRNewswire/ — Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that is collected and measured by means of digital devices such as portables, wearables, implantables, or digestibles. The data collected is typically used to explain, influence, and/or predict health-related outcomes. Based on system components, the smartphones and smartwatches segment held the most significant share of around 46.11%. For example, some smartwatches now feature optical sensors that continuously measure variations in blood volume and composition using a technology called photoplethysmography (PPG). And, according to data provided by Strategic Market Research, the digital biomarkers market is expected to grow at a CAGR of 35.7% to USD 23.31 Billion by 2030. Nemaura...
Today's Sponsors
Today's Sponsor